Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ...

For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 ...

Population-based screening for early-stage type 1 diabetes identifies most children who progress to clinical type 1 diabetes, ...

On Friday, the FDA expanded its approved use for kids 6 years and older who have Type 1 diabetes or those who require insulin ...

The FDA has approved the inhaled human insulin Afrezza (MannKind) for children aged 6 years or older with type 1 diabetes (T1D) or type 2 diabetes (T2D).

A recent systematic review and meta-analysis conducted by researchers from the Research Institute of the McGill University Health Center (The Institute) and published in eClinicalMedicine reveals that ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

GOOD MORNING. IT IS TIME FOR OUR KIDS CARE SEGMENT WHERE WE ARE SHINING A SPOTLIGHT ON KIDS WHO ARE DOING GREAT THINGS AND MAKING A DIFFERENCE IN THEIR COMMUNITY. I’M JOINED TODAY BY PORTIA, JOY AND ...

Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...

New global data show a dramatic surge in childhood and adolescent diabetes, especially type 2, yet improved care is helping reduce mortality worldwide. Study: Analysis of the global burden of diabetes ...